Skip to main content
TTrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor.

Fudan University

20 clinical trials · 20 recruiting · OTHER

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

Trials by Fudan University

RECRUITINGNCT04072653

Sentinel Node Biopsy Vs Observation After Axillary PET

Several researches have proved that avoiding axillary surgery does not worsen the outcome of breast cancer patients with relatively low risk. Based on the routine axillary imaging...

Sponsor: Fudan UniversityEnrolling: 15281 location
Breast Cancer
RECRUITINGPhase 2NCT06649331

Platform Study of ADC Rechallenge in ADC-treated Metastatic Breast Cancer

This is a prospective, open-label, multicenter, phase II platform trial. The purpose of this study is to test the safety and effectiveness of the antibody-conjugated drugs (ADCs)...

Sponsor: Fudan UniversityEnrolling: 1601 location
Advanced Breast CancerMetastatic Breast CancerTriple Negative Breast Cancer (TNBC)+2
RECRUITINGNCT07264556

Effect of OFA, OSA Versus Opioid-based Anesthesia on NETs and Cancer Cell Malignancy After Colorectal Cancer Surgery

Adult patients aged 18-80 years old, American Society of Anesthesiologists physical status I-III, who were scheduled for elective colorectal cancer surgery under general...

Sponsor: Fudan UniversityEnrolling: 901 location
Colorectal CancerOpioid-free AnesthesiaNETs
RECRUITINGPhase 2NCT06018896

Vitamin C to Quality of Life in Patients With Terminal Stage Pancreatic Cancer

The purpose of this study is to evaluate the efficacy of vitamin C in improving the quality of life for metastatic pancreatic cancer patients who are resistant to chemotherapy.

Sponsor: Fudan UniversityEnrolling: 201 location
Metastatic Pancreatic CancerTerminal Cancer
RECRUITINGPhase 2 / Phase 3NCT06095141

Cisplatin to Patients With Pancreatic Cancer and Homologous Recombination Deficiency

The purpose of this study is to evaluate the efficacy of cisplatin based regimen to patients with advanced pancreatic cancer and homologous recombination deficiency.

Sponsor: Fudan UniversityEnrolling: 301 location
Pancreatic AdenocarcinomaHomologous Recombination Deficiency
RECRUITINGPhase 2NCT06889610

A Phase II Clinical Study of Multimodal Ablation Combined With Systemic Drug Therapy for Advanced Solid Tumors.

This study focuses on the treatment of liver metastases from three common cancers: colorectal cancer, triple-negative breast cancer and melanoma. Currently, there are limitations...

Sponsor: Fudan UniversityEnrolling: 951 location
Triple Negative Breast Cancer MetastaticMelanoma MetastaticColorectal Cancer Metastatic
RECRUITINGPhase 2NCT06228963

Orelabrutinib in the Treatment of HP-positive Gastric MALT Lymphoma

Describe the efficacy and safety of Orelabrutinib in the treatment of HP-positive gastric MALT lymphoma

Sponsor: Fudan UniversityEnrolling: 1601 location
MALT Lymphoma of StomachHelicobacter Pylori Infection
RECRUITINGPhase 1 / Phase 2NCT07134153

Phase I/II Study of Intrathecal/Ommaya T-DXd in HER2-Expressing Breast Cancer With Leptomeningeal/Brain Metastases

Multiple trials confirm systemic T-DXd efficacy in HER2+ breast cancer with leptomeningeal/brain metastases, yet median LM survival remains 3-4 months, highlighting unmet needs....

Sponsor: Fudan UniversityEnrolling: 1392 locations
Breast Cancer
RECRUITINGPhase 2NCT05954429

A Study to Explore the Third-line Treatment of Fruquintinib Combined With Serplulimab in Advanced Non-liver-limited...

The aim of this clinical trial is to learn about efficacy of fruquintinib combined with serplulimab in patients with microsatellite stabilized mCRC who have failed standard...

Sponsor: Fudan UniversityEnrolling: 502 locations
Colorectal Cancer
RECRUITINGPhase 2NCT06970353

Phase II Trial of Tunlametinib in NRAS-Mutant Advanced Thyroid Cancer

This phase II trial evaluates Tunlametinib (MEK inhibitor) ± PD-1 in NRAS-mutant advanced thyroid cancer. Key Objectives: Assess efficacy (ORR by RECIST v1.1) Evaluate safety...

Sponsor: Fudan UniversityEnrolling: 401 location
Radioactive Iodine-refractory, Differentiated Thyroid Cancer With NRAS MutationAdvanced PDTC or ATC With NRAS Mutation
RECRUITINGNCT06530316

RET Inhibitor for Neoadjuvant Therapy in Locally Advanced RET-altered Thyroid Cancer

This study is a multicenter observational study. Patients receive neoadjuvant therapy with RET inhibitors in the real world, and those who can undergo surgery after neoadjuvant...

Sponsor: Fudan UniversityEnrolling: 481 location
Thyroid Cancer
RECRUITINGPhase 3NCT06554652

Selective Neck Dissection Versus Modified Neck Dissection in PTC

This study is a phase III, randomized controlled, open label non inferiority study. Patients who meet the inclusion criteria are randomly assigned 1:1 to either the experimental...

Sponsor: Fudan UniversityEnrolling: 2501 location
Thyroid Cancer
RECRUITINGPhase 2NCT05989425

Surufatinib as Neoadjuvant Treatment for Locally Advanced or Metastatic Differentiated Thyroid Cancer

Locally advanced thyroid cancer has a wide range of surgery, large trauma and high local recurrence rate. It is one of the main causes of death in patients with thyroid cancer....

Sponsor: Fudan UniversityEnrolling: 321 location
Differentiated Thyroid Cancer
RECRUITINGPhase 2NCT07194005

Conversion Therapy With RC48, Sintilimab, and SOX for HER2 1+/2+ Unresectable Gastric Cancer

This study aims to evaluate the efficacy of disitamab vedotin in combination with sintilimab and SOX as conversion therapy in patients with initially unresectable locally advanced...

Sponsor: Fudan UniversityEnrolling: 301 location
Gastric Cancer
RECRUITINGNCT05537129

Laparoscopic vs Open Total Gastrectomy for Gastric Cancer

The aim of the present study is to demonstrated the the safety and feasibility of laparoscopic total gastrectomy comparing with open total gastrectomy.

Sponsor: Fudan UniversityEnrolling: 6001 location
Gastric Cancer
RECRUITINGNCT05443841

Value of Pleural Lavage Cytology in Resectable Esophageal Carcinoma Eastern Cooperative Thoracic Oncology Projects...

Disease recurrence and metastasis are common after curative treatment for patients with esophageal cancer. Thus, it is important to identify the risk factors to predict disease...

Sponsor: Fudan UniversityEnrolling: 38511 locations
Esophageal Cancer
RECRUITINGNCT07165184

Incidence of 107 Lymph Node Metastasis

the study was to document the incidence o subcarinal lymph node metastasis, and the risk factors of metastasis.

Sponsor: Fudan UniversityEnrolling: 11001 location
Esophageal Cancer
RECRUITINGPhase 3NCT05674305

Radiotherapy Alone Versus Concurrent Chemo-radiotherapy for Nasopharyngeal Carcincoma Patients With Undectable EBV DNA...

The goal of this multicenter randomized non-inferior study is to compare radiotherapy alone versus concurrent chemoradiotherapy in locally advanced nasopharyngeal carcinoma...

Sponsor: Fudan UniversityEnrolling: 3661 location
Nasopharyngeal Carcinoma
RECRUITINGNCT06431997

A Study of the Intervention of Time-restricted Eating in High-risk Populations of GDM

This is a randomized controlled trial, aiming to investigate whether a time-restricted eating (TRE) can reduce the incidence of gestational diabetes mellitus (GDM) in high-risk...

Sponsor: Fudan UniversityEnrolling: 2401 location
Gestational Diabetes MellitusDietary HabitsLifestyle Intervention+1
RECRUITINGNCT06085690

Multicenter Clinical Translational Study of "ICU-NO CRBSI" Based on Improvement Science

The goal of this type of study is to construct the continuous quality promotion project "ICU-NO CRBSI(Catheter-Related Bloodstream Infection , CRBSI)" based on improvement...

Sponsor: Fudan UniversityEnrolling: 80501 location
CRBSI - Catheter Related Bloodstream InfectionEvidence-based Nursing PracticeCentral Venous Catheter Related Bloodstream Infection+4